Spectrum Laboratory Products has recalled approximately 6.2 kilograms of Estriol Micronized (USP), a hormonal medication used in prescription compounding. This recall was initiated because the supplier reported that testing results showed the drug was subpotent, meaning it did not meet the required strength specifications. Using a subpotent medication can lead to reduced effectiveness of the prescribed treatment, which may not provide the intended therapeutic benefits to patients.
The drug's active ingredients are lower than specified levels, which means patients may receive a lower dose of Estriol than their healthcare provider intended. This could result in ineffective treatment of hormonal conditions.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.